Cationic vesicles for efficient shRNA transfection in the MCF-7 breast cancer cell line

INTRODUCTION: Novel and safe delivery solutions for RNAi therapeutics are essential to obtain the full potential of cancer gene therapy. METHODS: In this study, cationic vesicular nanocarrier was applied for delivering lnc urothelial carcinoma-associated 1 (lnc UCA1) shRNA expression vector to MCF-7...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokhtary, Pardis, Javan, Bita, Sharbatkhari, Mahrokh, Soltani, Alireza, Erfani-Moghadam, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6228047/
https://www.ncbi.nlm.nih.gov/pubmed/30464462
http://dx.doi.org/10.2147/IJN.S177674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6228047/
https://www.ncbi.nlm.nih.gov/pubmed/30464462
http://dx.doi.org/10.2147/IJN.S177674

Ejemplares similares